Company intelligence / Profile preview

InnoSyn

Geleen, Netherlandsinnosynlifesciences.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

InnoSyn is an active CRO/CDMO specializing in sustainable chemical innovation for the pharmaceutical and related industries. The company leverages advanced technologies like flow chemistry, biocatalysis, and chemocatalysis to deliver custom synthesis, process optimization, and pilot-scale manufacturing services. It does not develop its own therapeutics but enables efficient production of high-quality compounds for clients across pharma and other sectors

Modalities: Small moleculeEnzyme
Industry: Drug Discovery Services

Partnerships

Genzai (AI partner for SynSilico joint venture targeting R&D innovation in life science/material science/chemical industries)

Beyond the preview

Go deeper on InnoSyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoSyn.

Explore the full profile